Real-Time email alerts. Get critical information on your stocks.
1 Which stocks are you watching?
 2 Where to send your updates?

Warner Chilcott plc (WCRX) Stock Quote

Detailed Quote for Warner Chilcott plc (WCRX) 
$ 19.21   -0.07 (-0.36%) Volume: 14.13 m 4:04 PM EDT May 17, 2013
After Hours:  $ 19.25   0.04 (+0.21%) Volume: 121.99 k 4:13 PM EDT May 17, 2013
Today 5d 1m 3m 1y more
Last Price
19.21
Change $
0.07
Change %
0.36%
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
19.29
High
19.60
Low
18.88
Prev Close
19.28
Last Trade
05/17/13
Volume
14.13 m
52 Wk Hi
20.51
52 Wk Low
10.845
Market Cap
4.81 b
Ex-Div Date
05/29/13
Div Rate
0.50
Yield
2.6028
Shares
250,590,087
EPS (TTM)
1.61
PE Ratio
9.10
Exchange
NGS
News and Media for Warner Chilcott plc  (WCRX) 
Sector News | Topic News
News for WCRX
Wed, May 15, 2013
9:00 AM The Reason It Trades, What's Moving DDD, MRK, GLW and WCRX - Marketwired
8:02 AM StockCall Early Morning Insight into WCRX, DVAX, ISIS, ACT, and AVNR - Accesswire
Tue, May 14, 2013
11:20 AM EmergingGrowth.com looks at Small Cap Specialty Pharmaceutical Plays - Accesswire
8:01 AM Perfect Trade Setups, How to Play NLY, CHK, WCRX and LLY - Marketwired
Mon, May 13, 2013
8:20 AM Free Research Reports on DRAM, SREV, TSRX and WCRX Issued by the Paragon Report - Marketwired
8:01 AM Announcement Under Irish Takeover Rules Relevant Securities in Issue - Globe Newswire
Sat, May 11, 2013
2:00 PM Secrets to Making Money in WCRX, T, GILD and IBM - Marketwired
Fri, May 10, 2013
2:46 PM Warner Chilcott Statement Regarding Market Speculation - Globe Newswire
2:45 PM Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc - PR Newswire
7:30 AM Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2013 - Globe Newswire
Thu, May 09, 2013
8:02 AM Warner Chilcott Announces FDA Approval of New Oral Contraceptive - Globe Newswire
Tue, May 07, 2013
4:30 PM Warner Chilcott Declares Semi-Annual Cash Dividend of $0.25 Per Share - Globe Newswire
Sat, May 04, 2013
11:00 AM The Real Story Behind JBLU, WCRX, CA and QLGC - Marketwired
Thu, May 02, 2013
4:15 PM Warner Chilcott Announces Changes to Board of Directors - Globe Newswire
Wed, May 01, 2013
4:15 PM Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2013 Financial Results - Globe Newswire
Mon, Apr 22, 2013
8:00 AM Warner Chilcott Announces FDA Approval of New Oral Contraceptive - Globe Newswire
Fri, Apr 12, 2013
8:00 AM Warner Chilcott Announces FDA Approval of DORYX(R) Delayed-Release 200 mg Tablets - Globe Newswire
Thu, Apr 11, 2013
8:00 AM StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics - PR Newswire
Wed, Mar 13, 2013
8:00 AM Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope - PR Newswire
Tue, Mar 12, 2013
8:00 AM A Forward Look into The Year Ahead - Research Report on Warner Chilcott Plc., Endo Health Solutions Inc., The Western Union Company, Euronet Worldwide, Inc. and The Procter & Gamble Company - PR Newswire
More News for WCRX >>

Tags for Warner Chilcott plc

Research stocks or mutual funds related to Warner Chilcott plc by keywords or tags. Find companies that have a similar focus to WCRX. The keywords below have been associated to WCRX by either user submission or electronic means.

pharmaceutical gmp biotech research pharmaceutical branding pharmaceutical industry strategy pharmaceutical market generic pharmaceutical pharmaceutical investment pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing pharma manufacturing pharma license generic products pharmaceutical cro pharma companies medical marketing active pharmaceutical ingredients pharmaceutical promotion pharmaceutical sales pharma pharmaceutical distributors mckesson products biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports biotech pharmaceutical pr Drugs massengill products pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharmaceutical article contract pharmaceutical pharmaceutical consulting otc products pharmaceutical industry biotech contract pharmaceutical test pharmaceutical studies pharmaceutical strategy pharmaceutical advances pharmaceutical specialty pharmaceutical jobs pharmaceutical out licensing pharmaceutical co promotion

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.